13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001599882
申报总市值
US$10.6亿
US$10.6亿
92 檔
15.7%
Q3 2025 季度申报显示，Rhenman & Partners Asset Management AB 披露的美股组合总市值为 US$10.6亿，涵盖 92 个不同之权益投资仓位。
Rhenman & Partners Asset Management AB 在 Q3 2025 进行了结构性的板块轮动与仓位换股。在开立 21 个全新仓位及加仓 41 档持股的同时，亦同步清仓 23 档并减仓 26 档标的。
在资产配置集中度方面，Rhenman & Partners Asset Management AB 的前 5 大核心持股（包含 BSX, LLY, ABBV 等）合计占整体申报市值的 15.7%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | 股票-医疗保健 | 4.73% | -3.03% | +47.97% | |
| 2 | LLY | Eli Lilly & Co | 股票-医疗保健 | 4.51% | -1.30% | -7.69% | |
| 3 | ABBV | Abbvie Inc | 股票-医疗保健 | 3.34% | +0.38% | +87.93% | |
| 4 | DHR | Danaher CORP | 股票-医疗保健 | 2.95% | +1.02% | +10.70% | |
| 5 | ALHC | Alignment Healthcare Inc | 股票-其他 | 2.86% | -0.05% | +14.92% | |
| 6 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 2.40% | -0.80% | +9.36% | |
| 7 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 2.39% | +2.15% | +105.49% | |
| 8 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 2.32% | +0.13% | +90.31% | |
| 9 | CVS | Cvs Health CORP | 股票-医疗保健 | 2.31% | -0.25% | -6.09% | |
| 10 | MCK | Mckesson CORP | 股票-医疗保健 | 2.27% | -0.62% | -4.03% | |
| 11 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 2.25% | -2.98% | +30.32% | |
| 12 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 2.24% | -0.41% | +70.33% | |
| 13 | MDT | Medtronic plc | 股票-医疗保健 | 2.16% | +0.11% | +14.21% | |
| 14 | COR | Cencora Inc | 股票-医疗保健 | 2.16% | -0.78% | +26.33% | |
| 15 | EXK | Exact Sciences CORP | 股票-原材料 | 2.11% | — | -0.57% | |
| 16 | INSM | Insmed Inc | 股票-医疗保健 | 2.10% | -1.69% | -24.82% | |
| 17 | GKOS | Glaukos CORP | 股票-医疗保健 | 2.08% | +0.45% | -2.13% | |
| 18 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 2.03% | -0.96% | -23.59% | |
| 19 | PODD | Insulet CORP | 股票-医疗保健 | 1.98% | +0.24% | +26.09% | |
| 20 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 1.80% | -0.07% | +39.41% | |
| 21 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.78% | -0.27% | -23.12% | |
| 22 | EHC | Encompass Health CORP | 股票-医疗保健 | 1.68% | +0.04% | -12.46% | |
| 23 | CAH | Cardinal Health Inc | 股票-医疗保健 | 1.63% | -0.20% | +70.91% | |
| 24 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.61% | -1.02% | +169.66% | |
| 25 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 1.61% | -0.92% | -37.74% | |
| 26 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 1.55% | — | +144.84% | |
| 27 | PRCT | Procept Biorobotics CORP | 股票-其他 | 1.54% | -0.73% | +105.26% | |
| 28 | CI | THE Cigna Group | 股票-医疗保健 | 1.48% | +0.19% | +45.31% | |
| 29 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.46% | -0.60% | +68.38% | |
| 30 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.39% | +0.22% | -12.84% | |
| 31 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.33% | +0.61% | +181.82% | |
| 32 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 1.31% | +0.24% | -57.17% | |
| 33 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.21% | — | +16.70% | |
| 34 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.15% | +0.84% | +24.81% | |
| 35 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.12% | +0.13% | +24.72% | |
| 36 | DOCS | Doximity Inc-class A | 股票-医疗保健 | 1.10% | -0.38% | +547.62% | |
| 37 | RPRX | Royalty Pharma plc | 股票-医疗保健 | 1.01% | -0.34% | -24.85% | |
| 38 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 0.98% | -0.75% | -52.33% | |
| 39 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.98% | +0.07% | — | |
| 40 | MDGL | Madrigal Pharmaceuticals Inc | 股票-医疗保健 | 0.93% | -1.14% | — | |
| 41 | BIIB | Biogen Inc | 股票-医疗保健 | 0.85% | -0.54% | +358.33% | |
| 42 | DVAX | Dynavax Technologies CORP | 股票-其他 | 0.85% | — | +36.64% | |
| 43 | ADPT | Adaptive Biotechnologies | 股票-其他 | 0.82% | -1.23% | EXIT | |
| 44 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.80% | +0.10% | -49.61% | |
| 45 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.76% | -0.06% | +37.12% | |
| 46 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 0.69% | +0.18% | — | |
| 47 | CNC | Centene CORP | 股票-医疗保健 | 0.67% | +1.48% | NEW | |
| 48 | STOK | Stoke Therapeutics Inc | 股票-其他 | 0.65% | -0.13% | — | |
| 49 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 0.63% | -0.17% | +154.46% | |
| 50 | AVR | Anteris Technologies Global | 股票-其他 | 0.62% | +0.44% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | DHR | Danaher CORP | +2% | +10.70% | 加仓 |
| 2 | IONS | Ionis Pharmaceuticals Inc | +2% | +70.33% | 加仓 |
| 3 | BSX | Boston Scientific CORP | +1.3% | +47.97% | 加仓 |
| 4 | EHC | Encompass Health CORP | +1.2% | -12.46% | 加仓 |
| 5 | ABBV | Abbvie Inc | +1.2% | +87.93% | 加仓 |
| 6 | COR | Cencora Inc | +1.1% | +26.33% | 加仓 |
| 7 | CYTK | Cytokinetics Inc | +1.1% | +144.84% | 加仓 |
| 8 | TMO | Thermo Fisher Scientific Inc | +0.9% | +169.66% | 加仓 |
| 9 | AXSM | Axsome Therapeutics Inc | +0.9% | +90.31% | 加仓 |
| 10 | AKRO | Akero Therapeutics Inc | +0.8% | +16.70% | 加仓 |
| 11 | ABT | Abbott Laboratories | +0.7% | +68.38% | 加仓 |
| 12 | NBIX | Neurocrine Biosciences Inc | +0.6% | -23.12% | 加仓 |
| 13 | LLY | Eli Lilly & Co | +0.6% | -7.69% | 加仓 |
| 14 | APLSUSD | Apellis Pharmaceuticals Inc | +0.5% | +149.06% | 加仓 |
| 15 | PEN | Penumbra Inc | +0.5% | -4.65% | 加仓 |
| 16 | DNTH | Dianthus Therapeutics Inc | +0.5% | +37.12% | 加仓 |
| 17 | CVS | Cvs Health CORP | +0.5% | -6.09% | 加仓 |
| 18 | INSM | Insmed Inc | +0.5% | -24.82% | 减仓 |
| 19 | GPCR | Structure Therapeutics Inc | +0.4% | +33.31% | 加仓 |
| 20 | CI | THE Cigna Group | +0.4% | +45.31% | 加仓 |
| 21 | ALGN | Align Technology Inc | +0.4% | +24.81% | 加仓 |
| 22 | SNDX | Syndax Pharmaceuticals Inc | +0.4% | — | 加仓 |
| 23 | VKTX | Viking Therapeutics Inc | +0.4% | +154.46% | 加仓 |
| 24 | BRKR | Bruker CORP | +0.4% | +25.14% | 加仓 |
| 25 | KURA | Kura Oncology Inc | +0.3% | +96.00% | 加仓 |
| 26 | PRVA | Privia Health Group Inc | +0.3% | +112.95% | 加仓 |
| 27 | ACLXGBX | Arcellx Inc | +0.3% | -2.97% | 加仓 |
| 28 | XENE | Xenon Pharmaceuticals Inc | +0.2% | +131.43% | 加仓 |
| 29 | INSP | Inspire Medical Systems Inc | +0.2% | +100.00% | 加仓 |
| 30 | ✓ | Merus N V | +0.2% | -53.88% | 减仓 |
| 31 | ANNX | Annexon Inc | +0.2% | +78.91% | 加仓 |
| 32 | ALKS | Alkermes plc | +0.2% | +141.03% | 加仓 |
| 33 | PODD | Insulet CORP | +0.1% | +26.09% | 减仓 |
| 34 | RLAY | Relay Therapeutics Inc | +0.1% | — | 不变 |
| 35 | ALNY | Alnylam Pharmaceuticals Inc | +0.1% | -37.74% | 减仓 |
| 36 | AVR | Anteris Technologies Global | +0.1% | — | 减仓 |
| 37 | MIRM | Mirum Pharmaceuticals Inc | +0.1% | -14.45% | 减仓 |
| 38 | BIIB | Biogen Inc | +0.1% | +358.33% | 加仓 |
| 39 | NUVL | Nuvalent Inc-a | +0.1% | — | 不变 |
| 40 | RARE | Ultragenyx Pharmaceutical In | +0.1% | +28.25% | 加仓 |
| 41 | BNTX | Biontech Se-adr | 0% | — | 加仓 |
| 42 | NRIX | Nurix Therapeutics Inc | 0% | +87.84% | 加仓 |
| 43 | DVAX | Dynavax Technologies CORP | 0% | +36.64% | 加仓 |
| 44 | IOVA | Iovance Biotherapeutics Inc | 0% | +69.46% | 加仓 |
| 45 | IMCR | Immunocore Holdings Plc-adr | 0% | — | 不变 |
| 46 | ALHC | Alignment Healthcare Inc | — | +14.92% | 加仓 |
| 47 | DNLI | Denali Therapeutics Inc | — | — | 不变 |
| 48 | XNCR | Xencor Inc | 0% | — | 减仓 |
| 49 | MLTX | Moonlake Immunotherapeutics | 0% | +360.00% | 加仓 |
| 50 | IQV | Iqvia Holdings Inc | 0% | +50.00% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Rhenman & Partners Asset Management AB 在 Q3 2025 季度的美股持仓总市值约为 US$10.6亿，共申报了 92 个公开持股仓位。
在 Q3 2025 季度，Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分别为：BSX (4.7%)、LLY (4.5%)、ABBV (3.3%)。其中最大持股仓位 BSX 占据整体投资组合约 4.7% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CAH
市值: US$1475.4万
本季最大获利了结 / 清仓标的
MOH
前期市值: US$2246.4万
在 Q3 2025 季度中，Rhenman & Partners Asset Management AB 共进行了 111 项持仓异动，包含新建仓 21 个仓位、加仓 41 个仓位、减仓 26 个仓位以及清仓 23 个仓位。 其中最大新建仓标的为 CAH。 本季清仓仓位包含 MOH。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。